Table 2 Anticancer potentialities of fucoidan (Fu), nanocurcumin (NCur), NCur-mediated SeNPs (NCur/SeNPs) and their composites against colorectal adenocarcinoma cells.
Anticancer agent | IC50 (mg/L)* | |
|---|---|---|
CaCo-2 | HT-29 | |
Fu | > 200a | > 200a |
NCur | 86.61 ± 5.67b# | 109.76 ± 8.42b^ |
NCur/SeNPs | 27.16 ± 2.18c# | 78.28 ± 3.85c^ |
Fu/NCur/SeNPs | 10.35 ± 0.83d# | 19.44 ± 1.39d^ |
Cisplatin | 25.56 ± 1.62c# | 83.77 ± 3.27c^ |